These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
385 related items for PubMed ID: 29492793
1. Risk of second malignancies among survivors of pediatric thyroid cancer. Adly MH, Sobhy M, Rezk MA, Ishak M, Afifi MA, Shafie AE, Ali MA, Zekri W, Alfaar AS, Rashed WM. Int J Clin Oncol; 2018 Aug; 23(4):625-633. PubMed ID: 29492793 [Abstract] [Full Text] [Related]
2. Increased risk of second primary malignancy in pediatric and young adult patients treated with radioactive iodine for differentiated thyroid cancer. Marti JL, Jain KS, Morris LG. Thyroid; 2015 Jun; 25(6):681-7. PubMed ID: 25851829 [Abstract] [Full Text] [Related]
3. Rising incidence of second cancers in patients with low-risk (T1N0) thyroid cancer who receive radioactive iodine therapy. Iyer NG, Morris LG, Tuttle RM, Shaha AR, Ganly I. Cancer; 2011 Oct 01; 117(19):4439-46. PubMed ID: 21432843 [Abstract] [Full Text] [Related]
4. Italian cancer figures, report 2013: Multiple tumours. AIRTUM Working GroupAIRTUM Working Group: tumori.infantili@registri-tumori.it.. Epidemiol Prev; 2013 Oct 01; 37(4-5 Suppl 1):1-152. PubMed ID: 24259384 [Abstract] [Full Text] [Related]
5. Risk of second primary malignancy in differentiated thyroid carcinoma treated with radioactive iodine therapy. Lang BH, Wong IO, Wong KP, Cowling BJ, Wan KY. Surgery; 2012 Jun 01; 151(6):844-50. PubMed ID: 22341041 [Abstract] [Full Text] [Related]
6. Risk of thyroid cancer in survivors of childhood cancer: results from the British Childhood Cancer Survivor Study. Taylor AJ, Croft AP, Palace AM, Winter DL, Reulen RC, Stiller CA, Stevens MC, Hawkins MM. Int J Cancer; 2009 Nov 15; 125(10):2400-5. PubMed ID: 19610069 [Abstract] [Full Text] [Related]
7. Pediatric thyroid cancer: An update from the SEER database 2007-2012. Dermody S, Walls A, Harley EH. Int J Pediatr Otorhinolaryngol; 2016 Oct 15; 89():121-6. PubMed ID: 27619041 [Abstract] [Full Text] [Related]
8. Thyroid carcinoma in children and adolescents. Danese D, Gardini A, Farsetti A, Sciacchitano S, Andreoli M, Pontecorvi A. Eur J Pediatr; 1997 Mar 15; 156(3):190-4. PubMed ID: 9083757 [Abstract] [Full Text] [Related]
9. The risk of second primary malignancies up to three decades after the treatment of differentiated thyroid cancer. Brown AP, Chen J, Hitchcock YJ, Szabo A, Shrieve DC, Tward JD. J Clin Endocrinol Metab; 2008 Feb 15; 93(2):504-15. PubMed ID: 18029468 [Abstract] [Full Text] [Related]
16. Risk of Second Primary Malignancies in Patients With Follicular Lymphoma: A United States Population-based Study. Giri S, Bhatt VR, Verma V, Pathak R, Bociek RG, Vose JM, Armitage JO. Clin Lymphoma Myeloma Leuk; 2017 Sep 15; 17(9):569-574. PubMed ID: 28709798 [Abstract] [Full Text] [Related]
17. Risk of selected subsequent carcinomas in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. Bassal M, Mertens AC, Taylor L, Neglia JP, Greffe BS, Hammond S, Ronckers CM, Friedman DL, Stovall M, Yasui YY, Robison LL, Meadows AT, Kadan-Lottick NS. J Clin Oncol; 2006 Jan 20; 24(3):476-83. PubMed ID: 16421424 [Abstract] [Full Text] [Related]
18. Risk of second primary malignancy after radioactive iodine treatment for differentiated thyroid carcinoma. Bhattacharyya N, Chien W. Ann Otol Rhinol Laryngol; 2006 Aug 20; 115(8):607-10. PubMed ID: 16944659 [Abstract] [Full Text] [Related]
20. Risk of second primary cancer after treatment for esophageal cancer: a pooled analysis of nine cancer registries. Zhu G, Chen Y, Zhu Z, Lu L, Bi X, Deng Q, Chen X, Su H, Liu Y, Guo H, Zheng T, Yu H, Zhang Y. Dis Esophagus; 2012 Aug 20; 25(6):505-11. PubMed ID: 22067063 [Abstract] [Full Text] [Related] Page: [Next] [New Search]